IP Library Patent Application 17223585
Patent Application
App. No. 17/223,585

METHOD OF TREATING THE BLOOD

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/223,585
Abstract

A method of stimulating human blood external of a patient donor has the steps of activating an acoustic shock wave or pressure pulse generator to emit acoustic shock waves or pressure pulses directed to impinge the blood, subjecting the blood to the acoustic shock waves or pressure pulses to form stimulated blood cells and transfusing the stimulated blood cells into the patient donor. The patient donor is infected with a virus and the blood exhibits at least traces of the virus. The emitted acoustic shock waves or pressure pulses stimulating the stimulated blood cells fragment the virus in the blood. The fragmented virus in the blood transfused back into the patient donor triggers a defensive immune response to kill the virus. The emitted acoustic shock waves or pressure pulses are preferably of a low energy. The emitted shock waves or pressure pulses stimulate the blood cells and fragment the virus in the absence of cell damaging cavitation due to an elasticity in the blood cells and a lack of elasticity in the virus. The blood is not filtered. The blood can be oxygenated via Extracorporeal membrane oxygenation (ECMO) after being stimulated.

Claims (15)

1 . A method of stimulating human blood external of a patient donor comprises the steps of:

activating an acoustic shock wave or pressure pulse generator to emit acoustic shock waves or pressure pulses directed to impinge the blood;

subjecting the blood to the acoustic shock waves or pressure pulses to form stimulated blood cells; and

transfusing the stimulated blood cells into the patient donor.

2 . The method of claim 1 wherein the patient donor is infected with a virus and the blood exhibits at least traces of the virus.

3 . The method of claim 2 wherein the emitted acoustic shock waves or pressure pulses stimulating the stimulated blood cells fragment the virus in the blood.

4 . The method of claim 3 wherein the fragmented virus in the blood transfused back into the patient donor triggers a defensive immune response to kill the virus.

5 . The method of claim 1 wherein the emitted acoustic shock waves or pressure pulses are of a low energy.

6 . The method of claim 1 wherein the emitted shock waves or pressure pulses stimulate the blood cells and fragment the virus in the absence of cell damaging cavitation due to an elasticity in the blood cells and a lack of elasticity in the virus.

7 . The method of claim 1 wherein the blood is not filtered.

8 . The method of claim 1 wherein the blood can be oxygenated via Extracorporeal membrane oxygenation (ECMO) after being stimulated.

9 . A composition of transfusable blood comprises:

a quantity of blood for transfusions; and

a plurality of fragmented viruses fragmented by acoustic shock waves or pressure pulses dispersed in the quantity of blood.

10 . The composition of claim 9 wherein the plurality of fragmented viruses when transfused into a virus infected patient activates a defensive immune response to kill the virus in the transfused patient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2021
From: WARLICK, JOHN F; HOPFENZITZ, NIKOLAUS
To: TISSUE REGENERATION TECHNOLOGIES, LLC
Reel/Frame 055839/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2021
From: TISSUE REGENERATION TECHNOLOGIES, LLC
To: SOFTWAVE TISSUE REGENERATION TECHNOLOGIES, LLC
Reel/Frame 055839/0613 →